U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 16

1.
Full record GDS5094

Stearoyl-CoA desaturase 1 inhibition effect on clear cell renal cell carcinoma cell lines

Analysis of clear cell renal cell carcinoma (ccRCC) cells treated with A939572, a stearoyl-CoA desaturase 1 (SCD1) inhibitor. SCD1 is overexpressed in ccRCC.Results provide insight into the role of SCD1 in the pathogenesis of ccRCC.
Organism:
Homo sapiens
Type:
Expression profiling by array, count, 2 agent, 4 cell line sets
Platform:
GPL570
Series:
GSE41485
8 Samples
Download data: CEL
2.

Expression data of A939572 SCD1 inhibitor treated ccRCC cells

(Submitter supplied) Presently, there is a deficiency of effective therapies designed to target clear cell renal cell carcinoma (ccRCC), with poor prognosis resulting in patients with advanced disease. Additionally, there is a lack of molecular factors which can be remedially targeted resulting in tumor specific inhibition, and therefore current therapeutic approaches often produce adverse side effects in patients. We identified that Stearoyl-CoA desaturase 1 (SCD1) was consistently overexpressed in patient ccRCC samples, and further investigation of SCD1 as a potential molecular target for ccRCC intervention utilizing a SCD1 inhibitor (A939572) resulted in tumor specific growth inhibition and induction of cell death. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS5094
Platform:
GPL570
8 Samples
Download data: CEL
Series
Accession:
GSE41485
ID:
200041485
3.

Expression data from renal cancer patient-derived xenograft tumor treated with temsirolimus or vehicle

(Submitter supplied) We kept 2 types of primary xenograft models (KURC;Kyoto University Renal Cancer-1,3) derived from human renal cell carcinoma tissues, and 10 mg/kg of temsirolimus or vehicle was intraperitoneally administered.We performed microarray analysis to compare the gene expression profile of temsirolimus-treated primary xenograft tumors with that of vehicle-treated.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL16686
9 Samples
Download data: CEL
Series
Accession:
GSE133446
ID:
200133446
4.

DNA methylation data from renal cancer patient-derived xenograft tumor treated with temsirolimus or vehicle

(Submitter supplied) We kept a primary xenograft models (KURC;Kyoto University Renal Cancer-3) derived from human renal cell carcinoma tissues, and 10 mg/kg of temsirolimus or vehicle was intraperitoneally administered.We performed DNA methylation analysis to compare the methylation profile of temsirolimus-treated primary xenograft tumors with that of vehicle-treated.
Organism:
Homo sapiens
Type:
Methylation profiling by array
Platform:
GPL13534
2 Samples
Download data: IDAT, TXT
Series
Accession:
GSE133444
ID:
200133444
5.

Gene array analysis of anaplastic thyroid carcinoma tissue versus matched and unmatched normal thyroid tissue

(Submitter supplied) Currently there is a lack of effective therapies which result in long-term durable response for patients presenting with anaplastic thyroid carcinoma (ATC), a very rare and lethal variant of thyroid cancer. ATC is resistant to chemotherapy, radiation, and targeted therapies currently available. In an effort to identify novel tumor-specific therapeutic targets, we performed high throughput gene array analysis screening numerous patient ATC tumor tissues, and compared their gene expression levels to matched and unmatched normal thyroid tissue samples.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
25 Samples
Download data: CEL
Series
Accession:
GSE65144
ID:
200065144
6.

Somatic Mutation Screen of Clear Cell RCC

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL9101
160 Samples
Download data: CEL, TXT
Series
Accession:
GSE17895
ID:
200017895
7.

Somatic Mutation Screen of Clear Cell RCC II

(Submitter supplied) Systematic somatic mutation screening of 4000 genes in human clear cell renal cell carcinoma. Information on corresponding somatic mutations in each sample can be found at http://www.sanger.ac.uk/genetics/CGP/Studies/.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL9101
115 Samples
Download data: CEL, TXT
Series
Accession:
GSE17818
ID:
200017818
8.

Somatic Mutation Screen of Clear Cell RCC I

(Submitter supplied) Systematic somatic mutation screening of 4000 genes in human clear cell renal cell carcinoma. Information on corresponding somatic mutations in each sample can be found at http://www.sanger.ac.uk/genetics/CGP/Studies/. These samples were run at a different facility than VARI - scmmlab.com
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL9101
45 Samples
Download data: CEL, TXT
Series
Accession:
GSE17816
ID:
200017816
9.

FGFR3-shRNA induced transcriptional changes in RT112 bladder cancer cells

(Submitter supplied) Aberrant activation of FGFR3 via overexpression or mutation is a frequent feature of bladder cancer; however, its molecular and cellular consequences and functional relevance to carcinogenesis are not well understood. In this study with a bladder carcinoma cell line expressing inducible FGFR3 shRNAs, we sought to identiy transcriptional targets of FGFR3 and investigate their contribution to bladder cancer development.
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS4454
Platform:
GPL570
24 Samples
Download data: CEL
Series
Accession:
GSE41035
ID:
200041035
10.
Full record GDS4454

Fibroblast growth factor receptor 3 depletion effect on bladder cancer cell line RT112

Analysis of bladder cancer cell line RT112 subjected to doxycycline-inducible, shRNA knockdown of FGFR3. Knockdown of FGFR3 in RT112 cells significantly attenuates tumor growth in vitro and in vivo. Results provide insight into the molecular mechanisms underlying FGFR3-driven bladder cancer.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 4 genotype/variation, 2 protocol sets
Platform:
GPL570
Series:
GSE41035
24 Samples
Download data: CEL
DataSet
Accession:
GDS4454
ID:
4454
11.

Comparison of gene expression profiles between SCD1 knockdown and vector control of Huh7 cells and PLC/PRF/5 cells by RNA-sequencing

(Submitter supplied) The purpose of this experiment is to search for the downstream target of SCD1
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL18460
4 Samples
Download data: TXT
Series
Accession:
GSE86602
ID:
200086602
12.

Expression data from renal cancer xenograft tumor treated with sunitinib or vehicle

(Submitter supplied) We established 3 types of primary xenograft models (KURC;Kyoto University Renal Cancer-1,2,3) derived from human renal cell carcinoma tissues, and 40 mg/day of sunitinib was orally administered. We performed microarray analysis to compare the gene expression profile of sunitinib-treated primary xenograft tumors (sensitive or resistant status) with that of vehicle-treated.
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS5815
Platform:
GPL6244
9 Samples
Download data: CEL
Series
Accession:
GSE66346
ID:
200066346
13.
Full record GDS5815

Sunitinib effect on renal cancer xenograft tumors

Analysis of Kyoto University Renal Cancer (KURC) xenograft tumor models, KURC1, KURC2, KURC3, treated with sunitinib, a small molecule inhibitor of receptor tyrosine kinases that is used to treat RC. Results provide insight into molecular mechanisms underlying acquired sunitinib resistance in RC.
Organism:
Homo sapiens
Type:
Expression profiling by array, count, 2 agent, 3 disease state, 3 individual sets
Platform:
GPL6244
Series:
GSE66346
9 Samples
Download data: CEL
14.

Transcriptome of cct3A(RNAi) planarians at 72 hours of regeneration

(Submitter supplied) We performed RNA-seq of whole starved cct3A(RNAi) planarians and controls at 72hR.
Organism:
Schmidtea mediterranea
Type:
Expression profiling by high throughput sequencing
Platform:
GPL20150
6 Samples
Download data: XLSX
Series
Accession:
GSE134013
ID:
200134013
15.

Expression data from 786-O renal cell cancer cells treated with pentamidine

(Submitter supplied) While early stages of clear cell renal cell carcinoma (ccRCC) are curable, survival outcome for metastatic ccRCC remains poor. The purpose of the current study was to apply a new individualized bioinformatics analysis (IBA) strategy to these transcriptome data in conjunction with Gene Set Enrichment Analysis of the Connectivity Map (C-MAP) database to identify and reposition FDA-approved drugs for anti-cancer therapy. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platforms:
GPL3921 GPL9197
8 Samples
Download data: CEL, CHP
Series
Accession:
GSE54709
ID:
200054709
16.

The role of chemerin in clear cell renal cell carcinoma

(Submitter supplied) The most common subset of renal carcinoma, clear cell renal cell carcinoma (ccRCC), is characterized by accentuated accumulation of neutral lipids in lipid droplets and adipogenic trans-differentiation. Because obesity is a major risk factor in the development of ccRCC, we investigated the role of the adipokines in driving lipid metabolism and tumorigenesis in ccRCC. Through in silico screening, we identified the adipokine chemerin as candidate pro-oncogenic factor that is overexpressed in tumors and prognostic for patient outcome. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL24676
12 Samples
Download data: XLSX
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=3|qty=3|blobid=MCID_665da985861d2b631c7072a0|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Support Center